{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1151.7","meta":{"versionId":"4","lastUpdated":"2016-07-14T01:00:02.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Oregon Urology Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-02-16"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2016-07-14"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1151.7","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1151.7"}],"version":"20160714","name":"LymphomaDiagnosisPriorToUrologyCare","title":"Lymphoma Diagnosis Prior to Urology Care","status":"active","experimental":false,"date":"2016-07-14T01:00:02-04:00","publisher":"Oregon Urology Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This grouping of diagnoses identifies patients who may be immunocompromised prior to urology care.),(Data Element Scope: The intent of this data element is to identify patients who may be immunocompromised prior to initiation of BCG for bladder cancer care.),(Inclusion Criteria: Only use codes which represent lymphoma.),(Exclusion Criteria: Exclude codes that do not represent lymphoma.)","compose":{"include":[{"system":"http://snomed.info/sct","concept":[{"code":"21964009","display":"Malignant lymphoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)"}]}]},"expansion":{"identifier":"urn:uuid:a84baef4-847c-44fc-a28b-00b19723d73a","timestamp":"2023-12-10T22:30:09-05:00","total":0}}